Glycopyrronium 25 mcg + Formoterol Fumarate 6 mcg is a dual-action inhalation therapy designed for the management of chronic obstructive pulmonary disease (COPD) and asthma. Glycopyrronium acts as a long-acting muscarinic antagonist (LAMA) that relaxes airway muscles, while Formoterol Fumarate is a long-acting β2-agonist (LABA) that helps open the airways for easier breathing. This combination provides rapid relief of bronchospasm, reduces exacerbations, and improves overall lung function. The inhaler ensures precise dosing for consistent symptom control.
